ACADIA Pharmaceuticals Stock Target Price and Analyst Consensus
| ACAD Stock | USD 22.95 0.92 4.18% |
The current analyst and expert consensus on ACADIA Pharmaceuticals is Buy with 6 buy recommendations. The current projected ACADIA Pharmaceuticals target price consensus is 31.21, with 20 analyst opinions. ACADIA Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected ACADIA Pharmaceuticals target price to derive its highest and lowest estimates based on target price estimated volatility of 2.0311. Check out Macroaxis Advice on ACADIA Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.
Lowest Forecast 28.4 | Highest Forecast 34.64 | Target Price 31.21 |
It's important to approach ACADIA Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
ACADIA Pharmaceuticals Target Price Consensus
ACADIA target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. ACADIA Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 20 | Buy |
Most ACADIA analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand ACADIA stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of ACADIA Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationACADIA Pharmaceuticals Target Price Projection
ACADIA Pharmaceuticals' current and average target prices are 22.95 and 31.21, respectively. The current price of ACADIA Pharmaceuticals is the price at which ACADIA Pharmaceuticals is currently trading. On the other hand, ACADIA Pharmaceuticals' target price is what analysts think the stock is worth. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
ACADIA Pharmaceuticals Market Quote on 17th of February 2026
Target Price
Analyst Consensus On ACADIA Pharmaceuticals Target Price
ACADIA Pharmaceuticals Analyst Ratings
ACADIA Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about ACADIA Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of ACADIA Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. ACADIA Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize ACADIA Pharmaceuticals price targets
ACADIA Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using ACADIA Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at ACADIA Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if ACADIA Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional ACADIA Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of ACADIA Pharmaceuticals is a key component of ACADIA Pharmaceuticals valuation and have some predictive power on the future returns of a ACADIA Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 90 shares | |
 | SRI Sustainable Growth Invested over 90 shares | |
 | ESG Investing Sold few shares | |
 | Tech Growth Invested over 90 shares | |
Check out Macroaxis Advice on ACADIA Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Please note, the presentation of ACADIA Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ACADIA Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ACADIA Pharmaceuticals' management manipulating its earnings.